102 related articles for article (PubMed ID: 19571320)
1. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair.
Fernandes MS; Reddy MM; Gonneville JR; DeRoo SC; Podar K; Griffin JD; Weinstock DM; Sattler M
Blood; 2009 Aug; 114(9):1813-9. PubMed ID: 19571320
[TBL] [Abstract][Full Text] [Related]
2. Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance.
Fitzgerald DM; Hastings PJ; Rosenberg SM
Annu Rev Cancer Biol; 2017 Mar; 1():119-140. PubMed ID: 29399660
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies.
Balboni B; Rinaldi F; Previtali V; Ciamarone A; Girotto S; Cavalli A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980703
[TBL] [Abstract][Full Text] [Related]
4. Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1.
Zeng F; Peng Y; Qin Y; Wang J; Jiang G; Feng W; Yuan Y
Cell Commun Signal; 2022 Dec; 20(1):199. PubMed ID: 36575478
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
Hochman MJ; Smith BD; Karantanos T; Braunstein EM; Gojo I; Jain T; Streiff MB; Moliterno AR; DeZern AE
Int J Hematol; 2023 Mar; 117(3):456-462. PubMed ID: 36181657
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.
Dey D; Hasan MM; Biswas P; Papadakos SP; Rayan RA; Tasnim S; Bilal M; Islam MJ; Arshe FA; Arshad EM; Farzana M; Rahaman TI; Baral SK; Paul P; Bibi S; Rahman MA; Kim B
Front Oncol; 2022; 12():899009. PubMed ID: 35719997
[TBL] [Abstract][Full Text] [Related]
7. Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia.
Ciaffaglione V; Consoli V; Intagliata S; Marrazzo A; Romeo G; Pittalà V; Greish K; Vanella L; Floresta G; Rescifina A; Salerno L; Sorrenti V
Molecules; 2022 May; 27(10):. PubMed ID: 35630697
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors protect the salivary gland from radiation damage by increasing DNA double-strand break repair.
Affandi T; Ohm AM; Gaillard D; Haas A; Reyland ME
J Biol Chem; 2021; 296():100401. PubMed ID: 33571522
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes.
Stetka J; Gursky J; Liñan Velasquez J; Mojzikova R; Vyhlidalova P; Vrablova L; Bartek J; Divoky V
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272770
[TBL] [Abstract][Full Text] [Related]
10. RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies.
Toma M; Sullivan-Reed K; Śliwiński T; Skorski T
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615159
[TBL] [Abstract][Full Text] [Related]
11. Stitching up broken DNA ends by FANCA.
Palovcak A; Liu W; Yuan F; Zhang Y
Mol Cell Oncol; 2018; 5(6):e1518101. PubMed ID: 30525096
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression.
Rebechi MT; Pratz KW
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28278729
[TBL] [Abstract][Full Text] [Related]
13. The Philadelphia chromosome in leukemogenesis.
Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
[TBL] [Abstract][Full Text] [Related]
14. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation.
Ahn JS; Li J; Chen E; Kent DG; Park HJ; Green AR
Oncogene; 2016 Apr; 35(17):2235-46. PubMed ID: 26234675
[TBL] [Abstract][Full Text] [Related]
15. JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response.
Chen E; Ahn JS; Massie CE; Clynes D; Godfrey AL; Li J; Park HJ; Nangalia J; Silber Y; Mullally A; Gibbons RJ; Green AR
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15190-5. PubMed ID: 25288776
[TBL] [Abstract][Full Text] [Related]
16. DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.
Mladenov E; Magin S; Soni A; Iliakis G
Front Oncol; 2013; 3():113. PubMed ID: 23675572
[TBL] [Abstract][Full Text] [Related]
17. New concepts for CML clonality.
Khorashad JS; Deininger MW; O'Hare T
Oncotarget; 2013 Jan; 4(1):7-8. PubMed ID: 23448894
[No Abstract] [Full Text] [Related]
18. Rad59 regulates association of Rad52 with DNA double-strand breaks.
Pannunzio NR; Manthey GM; Liddell LC; Fu BX; Roberts CM; Bailis AM
Microbiologyopen; 2012 Sep; 1(3):285-97. PubMed ID: 23170228
[TBL] [Abstract][Full Text] [Related]
19. Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.
Puthiyaveetil AG; Reilly CM; Pardee TS; Caudell DL
Leuk Res; 2013 Jan; 37(1):112-6. PubMed ID: 23131583
[TBL] [Abstract][Full Text] [Related]
20. JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?
Scott LM; Rebel VI
Am J Hematol; 2012 Nov; 87(11):1028-36. PubMed ID: 22641564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
